(Q39402027)

11 September 2017

1 reference

title

The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know? (English)

1 reference

11 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

James D Chalmers

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Simon Finch

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Holly R Keir

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

28 June 2017

1 reference

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1062-1072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

Understanding the mechanisms and drivers of antimicrobial resistance.

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Interdisciplinary research has consistently lower funding success

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Application of 'omics technologies to biomarker discovery in inflammatory lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Whole Genome Sequencing-Implications for Infection Prevention and Outbreak Investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Whole genome sequencing of meticillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Comparative genomics of BCG vaccines by whole-genome DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Heterogeneity in ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion system to virulence across closely related Staphylocccus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Whole-genome sequencing as standard practice for the analysis of clonality in outbreaks of meticillin-resistant Staphylococcus aureus in a paediatric setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Laboratory diagnosis of pneumonia in the molecular age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Lung microbiome dynamics in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Bacterial Topography of the Healthy Human Lower Respiratory Tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Microbiomes in respiratory health and disease: An Asia-Pacific perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Corticosteroids for community-acquired pneumonia: a critical view of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Sputum proteomics in inflammatory and suppurative respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Lipid mediator profiling in pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Application of metabolomics approaches to the study of respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Genomic responses in mouse models poorly mimic human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 - 2014).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Importance of Phosphoinositide 3-Kinase γ in the Host Defense against Pneumococcal Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Neutrophil extracellular traps kill bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

A new antibiotic kills pathogens without detectable resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.13106

21 January 2018

Identifiers

DOI

10.1111/RESP.13106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28657170%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference